Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Differentiating between various forms of hypertension presents challenges for physicians
• New devices for the treatment of atherosclerotic vascular disease: A view from pathology Masataka Nakano, MD; Renu Virmani
• Cerebrovascular pathologies may be unrecognized common etiologies of mild parkinsonian signs
• CRT showed positive effect on patients with minimal HF
• Endovascular approach for common femoral artery disease valid alternative to surgery
• FDA panel recommends approval for rivaroxaban
• Functional SYNTAX score appears more accurate than classic SYNTAX score
• Genetic mutations identified in sudden infant death syndrome
• Hard cardiac events in high-risk patients identified with MRI
• Healthy lifestyle linked to reductions in HF
• Hemodynamic response to LV pacing predictive of need for post-CRT remodeling
• Hypertension increased with decrease in slow-wave sleep
• Intra-aortic balloon counterpulsation failed to reduce MI size in patients with acute anterior MI without shock
• Left ventricular end-diastolic diameter predictive of myocardial recovery
• Low quality of life reported among internal medicine residents
• LV diastolic dysfunction linked to increased risk for HF
• Midregion pro-adrenomedullin predicted mortality rate in acute HF patients
• Mortality rates higher for patients with stroke admitted on weekends
• No difference in early vs. later CPR in cardiac arrest patients
• Perioperative low-dose carperitide may play role in patients with renal dysfunction undergoing CABG
• Potential reason for improved outcome found with GWTG-Stroke program
• Review: Single cryoballoon ablation procedure in patients with paroxysmal and persistent AF yields mixed results
• Technology-enhanced simulation associated with large effects in health professions education
• Varied rates of obstructive CAD suggest quality-improvement efforts
• Worse diastolic LV dysfunction predisposes to HF in diabetics
• Comparing strengths and limitations of hsCRP and CAC in refining CVD risk prediction Roger S. Blumenthal, MD; Michael J. Blaha, MD, MPH; Khurram Nasir, MD
• ARISTOTLE: Apixaban bests warfarin for stroke prevention in AF
• EXAMINATION: Xience V performed better than bare metal stents in PCI patients
• Newer-generation everolimus-eluting stent reduced definite stent thrombosis
• Obesity drugs: FDA says good guns or no guns Ryan Novosad, PharmD; Sara Brouse, PharmD, FCCP, BCPS, AQ-Cardiology